Matching articles for "Nimerix"
Issue 1726 · April 14, 2025 Free
Penmenvy — A Second Pentavalent Meningococcal Vaccine

The FDA has licensed the pentavalent vaccine Penmenvy (GSK) for prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, W, or Y (MenABCWY) in persons 10-25 years old.…

Med Lett Drugs Ther. 2025 Apr 14; 67(1726):57-9 doi:10.58347/tml.2025.1726a
The FDA has licensed the pentavalent vaccine Penmenvy (GSK) for prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, W, or Y (MenABCWY) in persons 10-25 years old. Penmenvy is the second pentavalent meningococcal vaccine to become available in the US; Penbraya was licensed in 2023.